Table of Content

1 Study Coverage
1.1 Neuroendocrine Tumor Drug Product Introduction
1.2 Market by Type
1.2.1 Global Neuroendocrine Tumor Drug Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Neuroendocrine Tumor Drug Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Neuroendocrine Tumor Drug Market by Region
1.4.1 Global Neuroendocrine Tumor Drug Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Neuroendocrine Tumor Drug Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Neuroendocrine Tumor Drug Revenue by Players
2.1.1 Global Neuroendocrine Tumor Drug Revenue by Players (2019-2024)
2.1.2 Global Neuroendocrine Tumor Drug Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Neuroendocrine Tumor Drug Revenue in 2024
2.2 Global Neuroendocrine Tumor Drug Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Neuroendocrine Tumor Drug Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Eisai
3.1.1 Eisai Information
3.1.2 Eisai Overview
3.1.3 Eisai Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.1.4 Eisai Related Developments
3.2 Exelixis Inc.
3.2.1 Exelixis Inc. Information
3.2.2 Exelixis Inc. Overview
3.2.3 Exelixis Inc. Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.2.4 Exelixis Inc. Related Developments
3.3 Foresee Pharmaceuticals LLC
3.3.1 Foresee Pharmaceuticals LLC Information
3.3.2 Foresee Pharmaceuticals LLC Overview
3.3.3 Foresee Pharmaceuticals LLC Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.3.4 Foresee Pharmaceuticals LLC Related Developments
3.4 Hutchison MediPharma Limited
3.4.1 Hutchison MediPharma Limited Information
3.4.2 Hutchison MediPharma Limited Overview
3.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.4.4 Hutchison MediPharma Limited Related Developments
3.5 Intezyne Inc
3.5.1 Intezyne Inc Information
3.5.2 Intezyne Inc Overview
3.5.3 Intezyne Inc Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.5.4 Intezyne Inc Related Developments
3.6 INVENT Pharmaceuticals Inc.
3.6.1 INVENT Pharmaceuticals Inc. Information
3.6.2 INVENT Pharmaceuticals Inc. Overview
3.6.3 INVENT Pharmaceuticals Inc. Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.6.4 INVENT Pharmaceuticals Inc. Related Developments
3.7 Ipsen S.A.
3.7.1 Ipsen S.A. Information
3.7.2 Ipsen S.A. Overview
3.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.7.4 Ipsen S.A. Related Developments
3.8 Jiangsu Hengrui Medicine Co. Ltd
3.8.1 Jiangsu Hengrui Medicine Co. Ltd Information
3.8.2 Jiangsu Hengrui Medicine Co. Ltd Overview
3.8.3 Jiangsu Hengrui Medicine Co. Ltd Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.8.4 Jiangsu Hengrui Medicine Co. Ltd Related Developments
3.9 Karyopharm Therapeutics Inc.
3.9.1 Karyopharm Therapeutics Inc. Information
3.9.2 Karyopharm Therapeutics Inc. Overview
3.9.3 Karyopharm Therapeutics Inc. Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.9.4 Karyopharm Therapeutics Inc. Related Developments
3.10 Lexicon Pharmaceuticals Inc.
3.10.1 Lexicon Pharmaceuticals Inc. Information
3.10.2 Lexicon Pharmaceuticals Inc. Overview
3.10.3 Lexicon Pharmaceuticals Inc. Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.10.4 Lexicon Pharmaceuticals Inc. Related Developments
3.11 Midatech Pharma Plc .
3.11.1 Midatech Pharma Plc . Information
3.11.2 Midatech Pharma Plc . Overview
3.11.3 Midatech Pharma Plc . Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.11.4 Midatech Pharma Plc . Related Developments
3.12 Millennium Pharmaceuticals Inc.
3.12.1 Millennium Pharmaceuticals Inc. Information
3.12.2 Millennium Pharmaceuticals Inc. Overview
3.12.3 Millennium Pharmaceuticals Inc. Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.12.4 Millennium Pharmaceuticals Inc. Related Developments
3.13 MolMed S.p.A.
3.13.1 MolMed S.p.A. Information
3.13.2 MolMed S.p.A. Overview
3.13.3 MolMed S.p.A. Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.13.4 MolMed S.p.A. Related Developments
3.14 Northwest Biotherapeutics Inc.
3.14.1 Northwest Biotherapeutics Inc. Information
3.14.2 Northwest Biotherapeutics Inc. Overview
3.14.3 Northwest Biotherapeutics Inc. Neuroendocrine Tumor Drug Revenue and Gross Margin (2019-2024)
3.14.4 Northwest Biotherapeutics Inc. Related Developments
4 Global Neuroendocrine Tumor Drug Market Insights
4.1 Global Neuroendocrine Tumor Drug Market Revenue 2019-2024
4.2 Global Neuroendocrine Tumor Drug Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Neuroendocrine Tumor Drug Revenue by Type
5.2 Global Neuroendocrine Tumor Drug Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Neuroendocrine Tumor Drug Revenue by Application
6.2 Global Neuroendocrine Tumor Drug Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Neuroendocrine Tumor Drug Market Size by Type
7.1.1 Americas Neuroendocrine Tumor Drug Revenue by Type (2019-2024)
7.1.2 Americas Neuroendocrine Tumor Drug Revenue Share by Type (2019-2024)
7.2 Americas Neuroendocrine Tumor Drug Market Size by Application
7.2.1 Americas Neuroendocrine Tumor Drug Revenue by Application (2019-2024)
7.2.2 Americas Neuroendocrine Tumor Drug Revenue Share by Application (2019-2024)
7.3 Americas Neuroendocrine Tumor Drug Market Size by Country
7.3.1 Americas Neuroendocrine Tumor Drug Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Neuroendocrine Tumor Drug Market Size by Type
8.1.1 Europe Neuroendocrine Tumor Drug Revenue by Type (2019-2024)
8.1.2 Europe Neuroendocrine Tumor Drug Revenue Share by Type (2019-2024)
8.2 Europe Neuroendocrine Tumor Drug Market Size by Application
8.2.1 Europe Neuroendocrine Tumor Drug Revenue by Application (2019-2024)
8.2.2 Europe Neuroendocrine Tumor Drug Revenue Share by Application (2019-2024)
8.3 Europe Neuroendocrine Tumor Drug Market Size by Country
8.3.1 Europe Neuroendocrine Tumor Drug Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Neuroendocrine Tumor Drug Market Size by Type
9.1.1 Asia Pacific Neuroendocrine Tumor Drug Revenue by Type (2019-2024)
9.1.2 Asia Pacific Neuroendocrine Tumor Drug Revenue Share by Type (2019-2024)
9.2 Asia Pacific Neuroendocrine Tumor Drug Market Size by Application
9.2.1 Asia Pacific Neuroendocrine Tumor Drug Revenue by Application (2019-2024)
9.2.2 Asia Pacific Neuroendocrine Tumor Drug Revenue Share by Application (2019-2024)
9.3 Asia Pacific Neuroendocrine Tumor Drug Market Size by Region
9.3.1 Asia Pacific Neuroendocrine Tumor Drug Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Neuroendocrine Tumor Drug Market Size by Type
10.1.1 Middle East and Africa Neuroendocrine Tumor Drug Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Neuroendocrine Tumor Drug Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Neuroendocrine Tumor Drug Market Size by Application
10.2.1 Middle East and Africa Neuroendocrine Tumor Drug Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Neuroendocrine Tumor Drug Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Neuroendocrine Tumor Drug Market Size by Country
10.3.1 Middle East and Africa Neuroendocrine Tumor Drug Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Neuroendocrine Tumor Drug Industry Trends
11.2 Neuroendocrine Tumor Drug Market Drivers
11.3 Neuroendocrine Tumor Drug Market Challenges
11.4 Neuroendocrine Tumor Drug Market Restraints
12 Neuroendocrine Tumor Drug Forecasted Market Size by Type
12.1 Global Neuroendocrine Tumor Drug Forecasted Revenue by Type
12.2 Global Neuroendocrine Tumor Drug Forecasted Market Size Growth by Type 2024-2030
13 Neuroendocrine Tumor Drug Forecasted Market Size by Application
13.1 Global Neuroendocrine Tumor Drug Forecasted Revenue by Application
13.2 Global Neuroendocrine Tumor Drug Forecasted Market Size Growth by Application 2024-2030
14 Global Neuroendocrine Tumor Drug Market Forecasts
14.1 Global Neuroendocrine Tumor Drug Market Revenue Forecasts 2024-2030
14.2 Global Neuroendocrine Tumor Drug Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer